Public Companies

Healthcare

QSAM
Coming October 18, 2023

QSAM Biosciences is developing next-generation nuclear medicines for the treatment of cancer and other diseases.

Consumer

Yerbaé
View On Demand

All-natural energy drink is catching the eye of top pros as they look for healthier alternatives to Red Bull and other energy drinks.

Healthcare

Kineta
View On Demand

Kineta, Inc. (Nasdaq: KA), announced today the achievement of a development milestone which triggers a $5 million payment from its research and development collaboration with Merck

Technology

Sonim Technologies
View On Demand

Sonim is following a trail blazed Range Rover, Yeti, and other brands from to turn their rugged heritage into a premium experience.

Healthcare

Kineta
View On Demand

How Kineta’s partnership with Merck could alter the future of cancer therapy by solving the challenge immuno-suppression